These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 5823751

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical experience with a new secretolytic drug.
    Villa R, Orlandini GC.
    Minerva Med; 1969 Sep 22; 60(76):3607-10. PubMed ID: 5823759
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical considerations on a recent preparation with bronchial secretolytic action].
    Santilli E, Castellana G.
    Minerva Med; 1969 Sep 22; 60(76):3583-93. PubMed ID: 5823755
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The parenteral use of a derivative of benzylamine in the control of tracheobronchial patological secretions].
    Bianchetti L, Chiri A.
    Minerva Med; 1969 Sep 19; 60(75):3521-4. PubMed ID: 5344812
    [No Abstract] [Full Text] [Related]

  • 7. [Effects of treatment with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride in oral adminstration on bronchial secretions; cytological findings].
    Lenzini L, Barnabè R.
    Minerva Med; 1969 Sep 22; 60(76):3580-2. PubMed ID: 5823754
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical experience with a new preparation with bronchosecretolytic action: Bisolvon or N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
    Ercillo L, Mollica G.
    Minerva Med; 1969 Sep 22; 60(76):3604-6. PubMed ID: 5823758
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [A derivative of benzyl-amine in the therapy of respiratory diseases in children].
    Gambi R, Ongaro F, Paoli R, Russo U.
    Minerva Med; 1969 Sep 22; 60(76):3575-9. PubMed ID: 5823753
    [No Abstract] [Full Text] [Related]

  • 13. [On the treatment of some forms of acute and chronic bronchial diseases with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
    Trombini V.
    Minerva Med; 1969 Sep 22; 60(76):3600-3. PubMed ID: 5823757
    [No Abstract] [Full Text] [Related]

  • 14. [Pulmonary volumetric changes caused by N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
    Brignani F, Cavalli A, Fabbri M, Melica A.
    Minerva Med; 1969 Sep 19; 60(75):3545-8. PubMed ID: 5344814
    [No Abstract] [Full Text] [Related]

  • 15. [Apropos of 27 patients treated with bisolvomycin].
    Breuil K.
    Bord Med; 1971 Sep 19; 4(9):2469-70. PubMed ID: 5123583
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinico-experimental studies of the mucolytic action of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride, in oral and parenteral administration, in acute and chronic pneumopathies].
    Carnimeo N, Fino E, Maiorano V, Marzullo F.
    Minerva Med; 1969 Sep 22; 60(76):3557-64. PubMed ID: 5823750
    [No Abstract] [Full Text] [Related]

  • 20. [Trial of N.80.BT. in the treatment of bronchoponeumopathies].
    Pidoux A, Kalb JC.
    J Med Lyon; 1972 Mar 20; 53(225):439-41. PubMed ID: 5053495
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.